Verzenio 150 mg/1

Verzenio 150 mg tablets are a pharmaceutical product used in cancer treatment. This medication, manufactured by Eli Lilly and Company, is designed to target specific pathways involved in cell growth and division.

Verzenio 150 mg tablets are commonly used in the treatment of certain types of cancer. The primary use of abemaciclib is to inhibit the growth of cancer cells by targeting specific proteins involved in cell cycle regulation. This medication is often prescribed in combination with other treatments to enhance its effectiveness. Patients may wonder, 'What is Verzenio used for?' and the answer lies in its role in managing advanced breast cancer and other malignancies.

Common effects of Verzenio 150 mg tablets may include fatigue, nausea, and diarrhea. Some users might experience a decrease in appetite or mild gastrointestinal discomfort. It's important to note that individual responses to the medication can vary, and not everyone will experience these effects.

Verzenio 150 mg tablets should be handled with care and stored as directed. It is crucial to follow the prescribed dosage and administration guidelines provided by a healthcare professional. Patients should inform their doctor about any pre-existing conditions or other medications they are taking to avoid potential complications.

Verzenio 150 mg tablets may interact with certain medications, including those that affect liver enzymes. It is advisable to avoid alcohol while taking this medication, as it can increase the risk of side effects. Patients should consult their healthcare provider before starting or stopping any medications while on Verzenio.